Valuation : Virbac

Market Cap 270.18Cr 313.22Cr 254.15Cr 231.54Cr 435.4Cr 30TCr 437.76Cr 3TCr 1.17TCr 15TCr 1.18TCr 1.15TCr 50TCr P/E 2026 *
15.8x
P/E 2027 * 14.3x
Enterprise Value 282.86Cr 327.91Cr 266.07Cr 242.4Cr 455.82Cr 31TCr 458.29Cr 3.15TCr 1.22TCr 16TCr 1.23TCr 1.2TCr 52TCr EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.69x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
1 day+0.39%
1 week-1.08%
Current month+0.16%
1 month-5.18%
3 months-8.56%
6 months-10.35%
Current year-8.03%
1 week 316
Extreme 316
327
1 month 316
Extreme 316
342.5
Current year 310.5
Extreme 310.5
381
1 year 297
Extreme 297
381
3 years 243
Extreme 243
392
5 years 220.5
Extreme 220.5
440.5
10 years 102.48
Extreme 102.479
440.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.39%-1.08% - - 313.8Cr
-0.13%+0.06%-49.41%-59.83% 3.19TCr
-0.02%-3.85%+35.15%+94.71% 1.2TCr
+0.46%+3.70%-17.96%+7.03% 395.74Cr
0.00%-1.98%-3.73%+16.85% 313.8Cr
+1.19%+2.74%+50.06%+35.71% 204.55Cr
-0.28%-0.99%+10.69%+5.80% 193.92Cr
+1.64%+7.32%+5.11%+165.75% 153.23Cr
+1.33%+1.10%-21.81%-7.35% 116.83Cr
+0.29%+1.78%-9.99%-40.85% 103.72Cr
Average +0.65%+0.93%-0.21%+24.20% 651.43Cr
Weighted average by Cap. +0.27%-0.17%-19.47%-6.93%

Financials

2026 *2027 *
Net sales 155.09Cr 179.8Cr 145.89Cr 132.91Cr 249.93Cr 17TCr 251.28Cr 1.72TCr 671.29Cr 8.68TCr 675.05Cr 660.41Cr 29TCr 164.73Cr 190.97Cr 154.95Cr 141.17Cr 265.46Cr 18TCr 266.9Cr 1.83TCr 713Cr 9.22TCr 717Cr 701.45Cr 31TCr
Net income 17Cr 20Cr 16Cr 15Cr 28Cr 1.88TCr 28Cr 190.29Cr 74Cr 957.68Cr 74Cr 73Cr 3.18TCr 19Cr 22Cr 18Cr 16Cr 31Cr 2.09TCr 31Cr 210.78Cr 82Cr 1.06TCr 83Cr 81Cr 3.52TCr
Net Debt 13Cr 15Cr 12Cr 11Cr 20Cr 1.39TCr 21Cr 140.95Cr 55Cr 709.36Cr 55Cr 54Cr 2.35TCr 7.52Cr 8.71Cr 7.07Cr 6.44Cr 12Cr 826.93Cr 12Cr 84Cr 33Cr 420.64Cr 33Cr 32Cr 1.39TCr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change
01/26/01 320.50 +0.16%
31/26/31 €320.00 -0.78%
28/26/28 €322.50 -0.31%
27/26/27 €323.50 -1.07%
26/26/26 €327.00 +0.93%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
322.50EUR
Average target price
411.88EUR
Spread / Average Target
+27.71%

Quarterly revenue - Rate of surprise